BIOS Capital Management’s Actuate Therapeutics, Inc. Common stock ACTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$60.9M Buy
9,965,079
+71,428
+0.7% +$436K 83.89% 1
2025
Q1
$67M Hold
9,893,651
84.59% 1
2024
Q4
$78.8M Buy
+9,893,651
New +$78.8M 83.69% 1